ProfileGDS4718 / 204264_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 95% 84% 96% 96% 83% 87% 96% 93% 96% 96% 95% 91% 86% 89% 94% 96% 89% 90% 74% 95% 96% 96% 96% 95% 86% 94% 82% 96% 85% 92% 82% 95% 96% 81% 83% 90% 93% 95% 82% 97% 87% 89% 87% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.571396
GSM549102patient 115, normal, homogenized [OPG study]10.324195
GSM549104patient 119, normal, homogenized [OPG study]8.3777784
GSM549108patient 138, normal, homogenized [OPG study]10.51696
GSM549119patient 077, normal, homogenized [OPG study]10.811896
GSM549133patient 032, cancer, homogenized [OPG study]8.4006283
GSM549139patient 042, cancer, homogenized [OPG study]8.6939187
GSM549099patient 107, normal, homogenized [OPG study]10.401996
GSM549109patient 139, normal, homogenized [OPG study]9.7947493
GSM549110patient 046, normal, homogenized [OPG study]10.713596
GSM549114patient 063, normal, homogenized [OPG study]10.883496
GSM549122patient 082, normal, homogenized [OPG study]10.268195
GSM549134patient 033, cancer, homogenized [OPG study]9.3163191
GSM549136patient 036, cancer, homogenized [OPG study]8.7170786
GSM549140patient 044, cancer, homogenized [OPG study]9.0271889
GSM549111patient 047, normal, homogenized [OPG study]10.003594
GSM549113patient 057, normal, homogenized [OPG study]10.918696
GSM549132patient 031, cancer, homogenized [OPG study]9.0562989
GSM549137patient 038, cancer, homogenized [OPG study]9.1295890
GSM549142patient 047, cancer, homogenized [OPG study]7.114874
GSM549100patient 110, normal, homogenized [OPG study]10.183795
GSM549107patient 135, normal, homogenized [OPG study]10.627196
GSM549115patient 068, normal, homogenized [OPG study]10.739596
GSM549116patient 072, normal, homogenized [OPG study]10.541296
GSM549120patient 078, normal, homogenized [OPG study]10.400995
GSM549131patient 030, cancer, homogenized [OPG study]8.7361186
GSM549118patient 074, normal, homogenized [OPG study]10.12694
GSM549129patient 027, cancer, homogenized [OPG study]8.1021182
GSM549123patient 088, normal, homogenized [OPG study]10.751696
GSM549124patient 006, cancer, homogenized [OPG study]8.4083685
GSM549126patient 015, cancer, homogenized [OPG study]9.4441792
GSM549128patient 025, cancer, homogenized [OPG study]8.1907282
GSM549103patient 117, normal, homogenized [OPG study]10.222895
GSM549117patient 073, normal, homogenized [OPG study]10.761996
GSM549138patient 041, cancer, homogenized [OPG study]7.9970381
GSM549141patient 045, cancer, homogenized [OPG study]8.3236883
GSM549130patient 028, cancer, homogenized [OPG study]9.0548690
GSM549101patient 111, normal, homogenized [OPG study]9.6946493
GSM549105patient 128, normal, homogenized [OPG study]10.173695
GSM549106patient 134, normal, homogenized [OPG study]8.2289182
GSM549112patient 048, normal, homogenized [OPG study]11.18797
GSM549125patient 011, cancer, homogenized [OPG study]8.7356387
GSM549127patient 024, cancer, homogenized [OPG study]9.0201289
GSM549135patient 035, cancer, homogenized [OPG study]8.7627887